Teladoc Health, Inc.
General ticker "TDOC" information:
- Sector: Health Care
- Industry: Medical - Healthcare Information Services
- Capitalization: $1.2B (TTM average)
Teladoc Health, Inc. follows the US Stock Market performance with the rate: 17.9%.
Estimated limits based on current volatility of 2.9%: low 5.73$, high 6.08$
Factors to consider:
- Earnings expected soon, date: 2026-10-28 amc
- Total employees count: 5600 (+1.8%) as of 2025
- US accounted for 81.9% of revenue in the fiscal year ended 2025-12-31
- Top business risk factors: Failure to achieve profitability, Asset impairment, Loss of large customers, Inability to compete, Cybersecurity threats
- Price in estimated range
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [5.30$, 11.89$]
- 2026-12-31 to 2027-12-31 estimated range: [4.88$, 11.17$]
Financial Metrics affecting the TDOC estimates:
- Positive: with PPE of -6.2 at the end of fiscal year the price was neutral
- Positive: 15.29 < Operating cash flow per share per price, % of 23.50
- Positive: -13.52 < Operating profit margin, % of -9.42
- Positive: -7.72 < Return on assets ratio (scaled to [-100,100]) of -6.55
- Positive: 42.26 < Shareholder equity ratio, % of 48.48 <= 49.86
- Positive: -40.59 < Investing cash flow per share per price, % of -21.23
- Positive: Industry inventory ratio change (median), % of -0.11 <= 0
Short-term TDOC quotes
Long-term TDOC plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $2,602.41MM | $2,569.57MM | $2,529.98MM |
| Operating Expenses | $2,850.97MM | $3,590.46MM | $2,792.93MM |
| Operating Income | $-248.55MM | $-1,020.89MM | $-262.95MM |
| Non-Operating Income | $28.95MM | $27.23MM | $27.43MM |
| Interest Expense | $22.28MM | $23.80MM | $19.71MM |
| R&D Expense | $348.52MM | $307.27MM | $277.92MM |
| Income(Loss) | $-219.61MM | $-993.65MM | $-235.53MM |
| Taxes | $0.76MM | $7.59MM | $-35.21MM |
| Net Income(Loss)* | $-220.37MM | $-1,001.25MM | $-200.32MM |
| Stockholders Equity | $2,326.07MM | $1,491.08MM | $1,385.71MM |
| Inventory | $29.51MM | $38.14MM | $38.20MM |
| Assets | $4,392.37MM | $3,516.52MM | $2,858.30MM |
| Operating Cash Flow | $350.02MM | $293.68MM | $294.36MM |
| Capital expenditure | $156.35MM | $10.79MM | $8.89MM |
| Investing Cash Flow | $-156.35MM | $-124.05MM | $-266.00MM |
| Financing Cash Flow | $10.85MM | $8.31MM | $-551.65MM |
| Earnings Per Share** | $-1.36 | $-5.87 | $-1.14 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.